RESPIRATORY SYNCYTIAL VIRUS (RSV) - ANVISA Registration 80213250112

Access comprehensive regulatory information for RESPIRATORY SYNCYTIAL VIRUS (RSV) in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 80213250112 and manufactured by R-BIOPHARM AG. The registration is held by PHAREBEE DIAGNOSTICOS COMERCIO IMPORTACAO E EXPORTACAO DE PRODUTOS LTDA with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including QUIDEL CORPORATION, HANGZHOU ALLTEST BIOTECH CO. LTD, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.